Reviva Pharmaceuticals Holdings Inc. - Warrants (25/12/2025)
RVPHW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$39.63K
Close$
$0.39
12990% upside
Current Fair Value
12990% upsideUndervalued by 12990% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $39,627.00 |
|---|---|
| Enterprise Value | $-17,414,029,960,373.00 |
| Earnings per Share | $-5.48 |
| Beta | -0.03 |
| Outstanding Shares | 13,209,000 |
Return
| Return on Equity | -188.17% |
|---|---|
| Return on Assets | -132.62% |
| Return on Invested Capital | -193.05% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.69 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 13, 2025
EPS
-$0.06
Est. -$0.09Revenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Reviva Pharmaceuticals Holdings Inc.
5 employees
Reviva Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing therapies that address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Reviva's primary ...